Drug Overdose Deaths: What Can Pharma Do?
Last week, the US Centers for Disease Control published a rather alarming report on drug overdose deaths in the US. Here are a few items which we found…
Menu
Global Formulation Report
The July/August issue of Drug Development and Delivery has an extensive report on the business and science of formulation and drug delivery. The report is based on the data…
Small Molecule PEGylation: An Idea Ready For Prime Time
At Lacerta Bio, we're big believers in the therapeutic benefits of drug delivery in its many forms. Today, another drug delivery effort earned an FDA approval. In this case, it's…
Drug Delivery is Alive and Well
The announcement of the Allergan acquisition of MAP Pharmaceuticals for nearly $1 billion (and the NuPathe approval) is a good reminder of the potential value (both clinical and financial) of reformulation and drug…
Predictions for 2013
Happy New Year! For many companies, 2012 was a challenging year. How will 2013 play out? Here are a few ideas we've discussed internally as we look forward to 2013:…
Repositioned Drugs Surpass New Brands
There are some very interesting data published yesterday on FDA approval statistics: It was in 1984 when FDA first added the 505(b)(2) pathway for drug approval, a hybrid between the…
Need for new drug delivery technologies is greater than ever
So said Shams Ruston from Labopharm at last week's Interphex conference in New York. We happen to agree. In fact, there are two ways to look at this. From the…
Flamel – Eclat and NicOx – Altacor: What can we learn?
The past seven days have brought us two very interesting transactions. First, on March 14, Lyon-based Flamel announced their acquisition of St. Louis-based Eclat Pharmaceuticals. The press release contains a…
Reformulating Injectables for Oral Delivery
Lacerta Bio was pleased to take part in a terrific overview of technologies for oral delivery of peptides and proteins: The oral delivery of biopharmaceuticals is highly desirable because it…
AAPS: Impressions and Observations
Lacerta Bio spent the week at the AAPS ( American Association of Pharmaceutical Scientists ) annual conference . Over 8,000 pharmaceutical scientists, service providers, and others came to AAPS in…